Extract:
The Bioanalytical Testing Services market is said to witness a significant growth during the forecast years between 2021 and 2028. Bioanalytical technologies were crucial in containing the COVID-19 pandemic, and they will continue to be critical in preventing future waves of the pandemic, as well as future infectious disease outbreaks. Mass spectrometry, immunoassays, and cell-based assays are among the bioanalytical services offered by companies like SGS for both small compounds and biologics.
Report Scope in detail:
This latest report edition of Bioanalytical Testing Services market has been added to our huge database of detailed reports and this envisions to shape the future of all the related businesses. Our team of learned research analysts have studied in-depth and curated the report based on several aspects which include the overview of the market, driving forces, growth rate, market trends, market size, opportunities and challenges of the market; along with detailed competitive analysis on the regional as well as global level. The Bioanalytical Testing Services market research report renders a thorough analysis of the market on a global aspect and aims on several market segmentation. This report also provides deeper perception into the latest trends of the market and pinpoints crucial product developments of the industry. Furthermore, the report collects numerous factors that have accredited to the growth of the market in the recent years.
Market Dynamics:
- The rising focus on biologics and biosimilars analytical testing, increasing preference for outsourcing analytical testing,
- Moreover, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries is boosting the growth of the market.
- Rising adoption of the Quality by Design approach is a major growth contributing factor to the market's growth.
- The scarcity of skilled specialists, on the other hand, is likely to limit the market's expansion during the forecast period. Pharmaceutical and biopharmaceutical firms have the greatest proportion of the market for bioanalytical testing services.
Bioanalytical Testing Services Market Segmentation:
By Molecule Type
- Small Molecules
- Large Molecules
By Test Type
- Pharmacokinetics
- Bioavailability and Bioequivalence Studies
- Pharmacodynamics
- Others
Regional Coverage
- North America
- United States
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Competitive Analysis:
Eminent market players have been outlined in order to extract improved insights into the worldwide businesses. Our research reports offer all-inclusive information on various top most manufacturers that are operational across global regions. We provide company profiles which include detailed overview of the company, business information, business performance, crucial strategies implemented through the years.
Few of the Key Players Covered in Our Report:
- ICON PLC
- Syneos Health
- Toxikon Corporation
- Charles River Laboratories International Inc.
- Laboratory Corporation of America Holdings
- WuXi PharmaTech (Cayman) Inc.
- Toxikon Corporation
- SGS SA
- LAB Holdings Inc.
- Pace Analytical Services, LLC
- Pharmaceutical Product Development LLC
- Frontage Labs
Impact of COVID19:
The COVID19 pandemic crippled the global economy, it resulted in a worldwide lockdown and this has majorly impacted numerous industries. Our industry experts are working round-the-clock to identify, accumulate and in-time deliver market analysis due to the effect of unprecedented decisions in COVID-19 repercussions on many businesses. The full version of this report will comprise the overall impact of the pandemic, and predicted alteration on the future outlook of the industry, by taking into the account the economic, political, technological and social parameters.
This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Estimation
Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.
Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.
Section 1: Executive Summary
1.1. Bioanalytical Testing Services Market Industry 360° outline, Year 2016 – 2028
1.2. Business Model Trends
1.3. Growth Trends
1.4. End-User/Test Type Trends
1.5. Regional Trends
Section 2: Market Dynamics - Bioanalytical Testing Services Market Industry Insights
2.1. Growth Drivers
2.2. Opportunities
2.3. Industry challenges
2.4. SWOT Analysis
2.5. Porter’s Analysis
2.6. Worldwide Industry Landscape, Year 2016 – 2028
2.7. Industry Segmentation
2.8. Technology & Invention landscape
2.9. Regional Landscape
2.9.1. North America
2.9.2. Europe
2.9.3. Asia-Pacific
2.9.4. South America
2.9.5. Middle East & Africa
2.10. Competitive Environment
Section 3: Global Bioanalytical Testing Services Market, By Molecule Type
3.1. Segmentation Analysis, By Molecule Type, 2016-2028
3.2. Market Share Segmentation Analysis, By Molecule Type, 2016-2028
3.3. Small Molecules
3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.4. Large Molecules
3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 4: Global Bioanalytical Testing Services Market, By Test Type
4.1. Segmentation Analysis, By Test Type, 2016-2028
4.2. Market Share Segmentation Analysis, By Test Type, 2016-2028
4.3. Pharmacokinetics
4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.4. Bioavailability and Bioequivalence Studies
4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.5. Pharmacodynamics
4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.6. Others
4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 5: Global Bioanalytical Testing Services Market, Regional Analysis
5.1. Global Bioanalytical Testing Services Market, Regional Analysis
5.2. North America, Country level Analysis
5.2.1. North America Bioanalytical Testing Services Market estimates and forecast with Growth rate analysis, By Molecule Type, 2016 – 2028
5.2.2. North America Bioanalytical Testing Services Market estimates and forecast with Growth rate analysis, By Test Type, 2016 – 2028
5.2.3. United States
5.2.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.2.4. Canada
5.2.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.2.5. Mexico
5.2.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3. Europe Country level Analysis
5.3.1. Europe Bioanalytical Testing Services Market estimates and forecast with Growth rate analysis, By Molecule Type, 2016 – 2028
5.3.2. Europe Bioanalytical Testing Services Market estimates and forecast with Growth rate analysis, By Test Type, 2016 – 2028
5.3.3. UK
5.3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3.4. Germany
5.3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3.5. France
5.3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3.6. Italy
5.3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3.7. Spain
5.3.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3.8. Russia
5.3.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.3.9. Rest of Europe
5.3.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4. Asia-Pacific Country level Analysis
5.4.1. Asia-Pacific Bioanalytical Testing Services Market estimates and forecast with Growth rate analysis, By Molecule Type, 2016 – 2028
5.4.2. Asia-Pacific Bioanalytical Testing Services Market estimates and forecast with Growth rate analysis, By Test Type, 2016 – 2028
5.4.3. China
5.4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4.4. India
5.4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4.5. Japan
5.4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4.6. Korea
5.4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4.7. Australia
5.4.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4.8. Southeast Asia
5.4.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4.9. Rest of Asia-Pacific
5.4.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.5. South America Country level Analysis
5.5.1. South America Bioanalytical Testing Services Market estimates and forecast with Growth rate analysis, By Molecule Type, 2016 – 2028
5.5.2. South America Bioanalytical Testing Services Market estimates and forecast with Growth rate analysis, By Test Type, 2016 – 2028
5.5.3. Brazil
5.5.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.5.4. Argentina
5.5.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.5.5. Colombia
5.5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.5.6. Rest of South America
5.5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.6. Middle East & Africa Country level Analysis
5.6.1. MEA Bioanalytical Testing Services Market estimates and forecast with Growth rate analysis, By Molecule Type, 2016 – 2028
5.6.2. MEA Bioanalytical Testing Services Market estimates and forecast with Growth rate analysis, By Test Type, 2016 – 2028
5.6.3. GCC
5.6.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.6.4. South Africa
5.6.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.6.5. Rest of Middle East & Africa
5.6.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 6: Company Profile - Bioanalytical Testing Services Market
6.1. ICON PLC
6.1.1. Business Overview
6.1.2. Product & Service Offering
6.1.3. Overall Revenue
6.1.4. Strategic Outlook
6.2. Syneos Health
6.2.1. Business Overview
6.2.2. Product & Service Offering
6.2.3. Overall Revenue
6.2.4. Strategic Outlook
6.3. Toxikon Corporation
6.3.1. Business Overview
6.3.2. Product & Service Offering
6.3.3. Overall Revenue
6.3.4. Strategic Outlook
6.4. Charles River Laboratories International Inc.
6.4.1. Business Overview
6.4.2. Product & Service Offering
6.4.3. Overall Revenue
6.4.4. Strategic Outlook
6.5. Laboratory Corporation of America Holdings
6.5.1. Business Overview
6.5.2. Product & Service Offering
6.5.3. Overall Revenue
6.5.4. Strategic Outlook
6.6. WuXi PharmaTech (Cayman) Inc.
6.6.1. Business Overview
6.6.2. Product & Service Offering
6.6.3. Overall Revenue
6.6.4. Strategic Outlook
6.7. Toxikon Corporation
6.7.1. Business Overview
6.7.2. Product & Service Offering
6.7.3. Overall Revenue
6.7.4. Strategic Outlook
6.8. SGS SA
6.8.1. Business Overview
6.8.2. Product & Service Offering
6.8.3. Overall Revenue
6.8.4. Strategic Outlook
6.9. LAB Holdings Inc.
6.9.1. Business Overview
6.9.2. Product & Service Offering
6.9.3. Overall Revenue
6.9.4. Strategic Outlook
6.10. Pace Analytical Services, LLC
6.10.1. Business Overview
6.10.2. Product & Service Offering
6.10.3. Overall Revenue
6.10.4. Strategic Outlook
6.11. Pharmaceutical Product Development LLC
6.11.1. Business Overview
6.11.2. Product & Service Offering
6.11.3. Overall Revenue
6.11.4. Strategic Outlook
6.12. Frontage Labs
6.12.1. Business Overview
6.12.2. Product & Service Offering
6.12.3. Overall Revenue
6.12.4. Strategic Outlook
*Market size and forecast will be provided from 2016-2028, and forecast period would be 2021-2028
*Details on financial performance and strategic moves and developments may not be captured for unlisted companies
*List of companies profiled in this TOC is tentative and may change after detailed analysis
